BACKGROUND The proportion of young patients with colorectal cancer(CRC), especially in their 40 s, is increasing worldwide.AIM To confirm the clinical characteristics of such patients, we planned a study comparing them to patients in their 30 s and 50 s.METHODS Patients undergoing primary resection for CRC, patients in their 30 s, 40 s and 50 s were included in the study. Patient and tumor characteristics, and perioperative and oncologic outcomes were compared.RESULTS Most clinical characteristics of 451(10.5%) patients in their 40 s were more similar to those of patients in their 30 s than those in their 50 s. On pathology data, there were more metastatic lesions(30 s vs 40 s vs 50 s; 17.5% vs 21.1% vs 14.9%, P = 0.012) in patients in their 40 s. There was a trend toward less frequent K-ras mutations among patients in their 40 s(48.5% vs 33.3% vs 44.5%, P = 0.064). The proportion of patients receiving postoperative chemotherapy was also significantly greater among patients in their 40 s(58.3% vs 63.9% vs 56.3%, P = 0.032). Five-year overall survival(OS) and disease-free survival(DFS) did not differ between the three groups(5-year OS, 92.2% vs 89.8% vs 92.2%, P = 0.804; 5-year total DFS, 98.6% vs 95.7% vs 96.1%, P = 0.754; 5-year local DFS, 98.6% vs 94.3% vs 94.9%, P = 0.579; 5-year systemic DFS, 86.4% vs 87.9 % vs 86.4%, P = 0.908).CONCLUSION Patients with CRC in their 40 s showed significantly more numerous metastatic lesions. The oncologic outcome of stage 1-3 patients in their 40 s was not inferior compared to that of those in their 30 s and 50 s.